BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 21968148)

  • 1. Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population.
    Behar DM; Kedem E; Rosset S; Haileselassie Y; Tzur S; Kra-Oz Z; Wasser WG; Shenhar Y; Shahar E; Hassoun G; Maor C; Wolday D; Pollack S; Skorecki K
    Am J Nephrol; 2011; 34(5):452-9. PubMed ID: 21968148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High population frequencies of APOL1 risk variants are associated with increased prevalence of non-diabetic chronic kidney disease in the Igbo people from south-eastern Nigeria.
    Ulasi II; Tzur S; Wasser WG; Shemer R; Kruzel E; Feigin E; Ijoma CK; Onodugo OD; Okoye JU; Arodiwe EB; Ifebunandu NA; Chukwuka CJ; Onyedum CC; Ijoma UN; Nna E; Onuigbo M; Rosset S; Skorecki K
    Nephron Clin Pract; 2013; 123(1-2):123-8. PubMed ID: 23860441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans.
    Kasembeli AN; Duarte R; Ramsay M; Mosiane P; Dickens C; Dix-Peek T; Limou S; Sezgin E; Nelson GW; Fogo AB; Goetsch S; Kopp JB; Winkler CA; Naicker S
    J Am Soc Nephrol; 2015 Nov; 26(11):2882-90. PubMed ID: 25788523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequencing rare and common APOL1 coding variants to determine kidney disease risk.
    Limou S; Nelson GW; Lecordier L; An P; O'hUigin CS; David VA; Binns-Roemer EA; Guiblet WM; Oleksyk TK; Pays E; Kopp JB; Winkler CA
    Kidney Int; 2015 Oct; 88(4):754-63. PubMed ID: 25993319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of APOL1 polymorphism and IL-1β priming in the entry and persistence of HIV-1 in human podocytes.
    Mikulak J; Oriolo F; Portale F; Tentorio P; Lan X; Saleem MA; Skorecki K; Singhal PC; Mavilio D
    Retrovirology; 2016 Sep; 13(1):63. PubMed ID: 27599995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOL1 localization in normal kidney and nondiabetic kidney disease.
    Madhavan SM; O'Toole JF; Konieczkowski M; Ganesan S; Bruggeman LA; Sedor JR
    J Am Soc Nephrol; 2011 Nov; 22(11):2119-28. PubMed ID: 21997392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics.
    Atta MG; Estrella MM; Kuperman M; Foy MC; Fine DM; Racusen LC; Lucas GM; Nelson GW; Warner AC; Winkler CA; Kopp JB
    Kidney Int; 2012 Aug; 82(3):338-43. PubMed ID: 22495294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.
    Kopp JB; Nelson GW; Sampath K; Johnson RC; Genovese G; An P; Friedman D; Briggs W; Dart R; Korbet S; Mokrzycki MH; Kimmel PL; Limou S; Ahuja TS; Berns JS; Fryc J; Simon EE; Smith MC; Trachtman H; Michel DM; Schelling JR; Vlahov D; Pollak M; Winkler CA
    J Am Soc Nephrol; 2011 Nov; 22(11):2129-37. PubMed ID: 21997394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.
    Papeta N; Kiryluk K; Patel A; Sterken R; Kacak N; Snyder HJ; Imus PH; Mhatre AN; Lawani AK; Julian BA; Wyatt RJ; Novak J; Wyatt CM; Ross MJ; Winston JA; Klotman ME; Cohen DJ; Appel GB; D'Agati VD; Klotman PE; Gharavi AG
    J Am Soc Nephrol; 2011 Nov; 22(11):1991-6. PubMed ID: 21997397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High risk APOL1 genotypes and kidney disease among treatment naïve HIV patients at Kano, Nigeria.
    Abdu A; Duarte R; Dickens C; Dix-Peek T; Bala SM; Ademola B; Naicker S
    PLoS One; 2022; 17(10):e0275949. PubMed ID: 36227935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
    Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
    Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease.
    Fine DM; Wasser WG; Estrella MM; Atta MG; Kuperman M; Shemer R; Rajasekaran A; Tzur S; Racusen LC; Skorecki K
    J Am Soc Nephrol; 2012 Feb; 23(2):343-50. PubMed ID: 22135313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOL1 variants in HIV-associated nephropathy: just one piece of the puzzle.
    Hays T; Wyatt CM
    Kidney Int; 2012 Aug; 82(3):259-60. PubMed ID: 22791322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.
    Tzur S; Rosset S; Shemer R; Yudkovsky G; Selig S; Tarekegn A; Bekele E; Bradman N; Wasser WG; Behar DM; Skorecki K
    Hum Genet; 2010 Sep; 128(3):345-50. PubMed ID: 20635188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOL1 variants associate with increased risk of CKD among African Americans.
    Foster MC; Coresh J; Fornage M; Astor BC; Grams M; Franceschini N; Boerwinkle E; Parekh RS; Kao WH
    J Am Soc Nephrol; 2013 Sep; 24(9):1484-91. PubMed ID: 23766536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOL1 genetic variants, chronic kidney diseases and hypertension in mixed ancestry South Africans.
    Matsha TE; Kengne AP; Masconi KL; Yako YY; Erasmus RT
    BMC Genet; 2015 Jun; 16():69. PubMed ID: 26112018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of HIV-associated nephropathy in Ethiopians.
    Behar DM; Shlush LI; Maor C; Lorber M; Skorecki K
    Am J Kidney Dis; 2006 Jan; 47(1):88-94. PubMed ID: 16377389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy.
    Atta MG; Estrella MM; Skorecki KL; Kopp JB; Winkler CA; Wasser WG; Shemer R; Racusen LC; Kuperman M; Foy MC; Lucas GM; Fine DM
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):262-70. PubMed ID: 26668025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease.
    Tzur S; Rosset S; Skorecki K; Wasser WG
    Nephrol Dial Transplant; 2012 Apr; 27(4):1498-505. PubMed ID: 22357707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Variants of
    Hung RKY; Binns-Roemer E; Booth JW; Hilton R; Harber M; Santana-Suarez B; Campbell L; Fox J; Ustianowski A; Cosgrove C; Burns JE; Clarke A; Price DA; Chadwick D; Onyango D; Hamzah L; Bramham K; Sabin CA; Winkler CA; Post FA;
    Kidney Int Rep; 2022 Apr; 7(4):786-796. PubMed ID: 35497797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.